Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for stage I-III HER2-positive breast cancer: Results of a single-arm pilot clinical trial

被引：0
|
作者：
Jiang, Jun [1 ]
机构：
[1] Army Med Univ, Chongqing, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS11-24
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase I/II Trial of Ibrutinib Plus Trastuzumab in HER2-Positive Metastatic Breast Cancer
    O'Shaughnessy, Joyce
    Glidden, Andrea
    Locke, Tracy
    Scales, Amy
    CANCER RESEARCH, 2024, 84 (09)
  • [42] Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
    Wu, Jiong
    Jiang, Zefei
    Liu, Zhenzhen
    Yang, Benlong
    Yang, Hongjian
    Tang, Jinhai
    Wang, Kun
    Liu, Yunjiang
    Wang, Haibo
    Fu, Peifen
    Zhang, Shuqun
    Liu, Qiang
    Wang, Shusen
    Huang, Jian
    Wang, Chuan
    Wang, Shu
    Wang, Yongsheng
    Zhen, Linlin
    Zhu, Xiaoyu
    Wu, Fei
    Lin, Xiang
    Zou, Jianjun
    BMC MEDICINE, 2022, 20 (01)
  • [43] Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
    Jiong Wu
    Zefei Jiang
    Zhenzhen Liu
    Benlong Yang
    Hongjian Yang
    Jinhai Tang
    Kun Wang
    Yunjiang Liu
    Haibo Wang
    Peifen Fu
    Shuqun Zhang
    Qiang Liu
    Shusen Wang
    Jian Huang
    Chuan Wang
    Shu Wang
    Yongsheng Wang
    Linlin Zhen
    Xiaoyu Zhu
    Fei Wu
    Xiang Lin
    Jianjun Zou
    BMC Medicine, 20
  • [44] Trastuzumab plus chemotherapy improves survival in early-stage HER2-positive breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (07): : 851 - +
  • [45] Trastuzumab plus Paclitaxel in HER2-positive Breast Cancer
    不详
    GYNAKOLOGE, 2016, 49 (08): : 558 - 558
  • [46] Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer
    Palmieri, Carlo
    Macpherson, Iain R. J.
    Yan, Kelvin
    Ades, Felipe
    Riddle, Pippa
    Ahmed, Riz
    Owadally, Waheeda
    Stanley, Barbara
    Shah, Deep
    Gojis, Ondrej
    Januszewski, Adam
    Lewanski, Conrad
    Asher, Rebecca
    Lythgoe, Daniel
    de Azambuja, Evandro
    Beresford, Mark
    Howell, Sacha J.
    ONCOTARGET, 2016, 7 (11) : 13209 - 13220
  • [47] Neoadjuvant pyrotinib and inetetamab in combination with chemotherapy for locally advanced HER2-positive breast cancer (NeoPICD study): A prospective, multicenter, open-label, single-arm study.
    Xu, Yiying
    Wu, Xue
    Yang, Chenghui
    Xia, Erjie
    Wang, Yinghao
    Dai, Xuanxuan
    Liu, Haiguang
    Chen, Yizuo
    Wang, Wenqian
    Guo, Guilong
    Wu, Weili
    Li, Xiaoyang
    Wang, Ouchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial
    Yan, Min
    Ouyang, Quchang
    Sun, Tao
    Niu, Limin
    Yang, Jin
    Li, Li
    Song, Yuhua
    Hao, Chunfang
    Chen, Zhanhong
    Liu, Zhenzhen
    Lv, Huimin
    Zhang, Mengwei
    Liu, Liping
    Yang, Xiaohong
    Xiao, Huawu
    Gao, Zhichao
    Li, Xiaorui
    Dong, Fangyuan
    Zhang, Lingxiao
    Dong, Danfeng
    Chen, Xiuchun
    Qiao, Jianghua
    Zhang, Guifang
    Zeng, Huiai
    Wang, Jing
    Sun, Huihui
    Feng, Yajing
    Chen, Yuting
    Xia, Fangzhou
    ECLINICALMEDICINE, 2024, 76
  • [49] Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab
    Fujita, Noriko
    Enomoto, Yukie
    Inakami, Keiko
    Yanagisawa, Tetsu
    Iguchi, Chikage
    Aono, Toyokazu
    Nomura, Takashi
    Yamamoto, Hitoshi
    Kasugai, Tsutomu
    Shiba, Eiichi
    ONCOLOGY, 2020, 98 (01) : 35 - 41
  • [50] Adjuvant Trastuzumab Emtansine Versus Paclitaxel and Trastuzumab in Stage I HER2-Positive Breast Cancer: The ATEMPT Trial
    Khattak, Monica N.
    Chichura, Anna M.
    Lang, Julie E.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 1423 - 1427
12345